Information on changes in the urinary excretion pattern of porphynns can be especially useful in the diagnosis of disorders of porphyrin metabolism. Most clinical laboratory procedures are designed for assay of uroporphynn and coproporphyrin only, and in many cases even these are not cleanly separated. Hence, we developed a "high-performance" liquid-chromatographic procedure to separate and quantify all five urinary porphyrins-that is, those with four througheight carboxyl groups. Before chromatography, the porphynns are isolated from other urinary components by two simple, rapid pretreatment steps, then injected into the chromatograph in nonestenfied form. They are separated and eluted with a step gradient of methanol/phosphate buffer, pH 3.0, in which the methanol content is first 650, then 850 mL/L. 
For several years, we have successfully used a simple screening procedure combined with thin-layer chromatography for the diagnosis of porphyrin disorders (1). Although cost effective, the procedure has its limitations:
the subjective interpretation of screening results can create problems, and even the best screening procedure must occasionally be supplemented with quantitative data. Other limitations are that current techniques for quantitative determinations of urine porphyrins rely on either column or thin-layer chromatography or multiple extractions of urine with organic and aqueous solvents. Both methods require considerable time, and the solvent-extraction procedures are quite tedious. Neither approach fully and effectively separates the compounds being analyzed when limited to methods well adapted to the routine clinical laboratory.
Moreover, minor products of porphyrin metabolism not usually measured by these methods may be of clinical significance. Advances in the technology of "high-performance" [2] [3] [4] [5] . We considered that further refinements could be obtained by some preliminary processing of the specimen, by eliminating the requirement of continuous gradient elution, and by analyzing acid porphyrins rather than esters (6) .
Here we describe determination of urinary porphyrins by HPLC. Specimen preparation is simple, involving the isolation of porphyrins from other urine components by ionexchange chromatography. Porphyrins are then separated into uroporphyrin, coproporphyrin, and the hepta-, hexa-, and pentacarboxyl forms by the HPLC system. Quantification by fluorometry allows the accurate measurement of as little as 1 ng of material. 
Materials and Methods

Reagents and Materials
Preparation of Aqueous Methanol Solvents
Preparation of DEAE-Cellulose Columns
Place 25 g of dry DEAE-eellulose in a glass beaker and add 80 mL of sodium phosphate, 100 mniol/L, pH 3.5. Adjust the stirred slurry to pH 5.0 with 6 mol/L HC1. Pipet 2.2 mL of the slurry into 10-mL Econocolumns to give a packed volume of 1 mL.
Porphyrin Standards
Dissolve 100 g of porphyrin acid markers (containing approximately equal amounts of porphyrins with two and four through eight COOH groups) in 5 mL of aqueous methanol, 800 mLIL, pH 7.5. Similarly, dissolve 5 pg of coproporphyrin fluorescence standard in another 5 mL of the same solvent. Stored well sealed in the dark at 4#{176}C, these porphyrin solutions are stable for at least one month.
To determine accurately the concentration of the coproporphyrin fluorescence standard, measure the absorbanceof the methanol solution in a cuvette having a 10-mm light path. At the Soret peak (392 nm) the molar absorptivity is 1.88 x i0. Note that all these porphyrins have a very sharp spectral peak of high molar absorptivity near 392 nm, which means that slight variations in instrument adjustments can have a relatively large influence on the reading. Hence, it is essential that the concentration be calculated from the amount of absorbance at the peak, whether this occurs slightly above or below 392 urn.
Specimen Collection and Preparation
Urine should be collected for 24 h in a dark-brown container, to which 5 g of sodium bicarbonate has been added to keep the specimen near neutral or slightly alkaline. Specimens can be stored at 4#{176}C for as long as a week; store frozen for longer intervals.
Aspirate a 10-mL aliquot of urine through the DEAEcellulose column. Using a plastic syringe, pass 10 mL of the 800 mL/L methanol solvent, pH 7.5, through a SEP-PAK column, followed by 10 mL of sodium phosphate, 10 mniol/L, pH 3.5. With a different syringe, inject the entire eluate from the DEAE-cellulose column onto the SEP-PAK column. Wash the SEP-PAK column with another 10 mL of the sodium phosphate buffer. Elute the porphyrins by slowly passing 2 mL of the 800 mLIL methanol solvent, pH 7.5, through the column; wait about 1 mm, then complete the elution with an additional 3 mL of the same solvent.
Chromatography System
The HPLC system consists of a M6000 pump, U6K injector, and RCM-100 radial compression module containing a 10-sm particle size pBondapak C18radial compression column, 5.8 mm i.d. x 8 cm (all from Waters Associates). A 3.9 mm i.d. x 23 mm guard column packed with C1WCorasil, 37-to 50-pm particle size, is placed between the pump and the analytical column. The detector is a Schoeffel FS 970 L.C. fluorometer coupled to a 10 mV recorder. The continuously variable excitation wavelength is set at 405 urn, and a secondary ifiter with a cutoff at 580 urn is used.
Procedure
The basic procedure is as follows:
To equilibrate the HPLC system, run the 650 mL/L methanol solvent, pH 3.0, through it at 1.5 mLlmin until a steady baseline is achieved-about 10 mm. Then inject the porphyrin-containing solution ( 
Measurements and Calculations
For each specimen, identify the urinary porphyrins by their retention times. Measure the peak heights of coproporphyrin, uroporphyrin, and any other porphyrins that elute. For each peak, calculate as follows: A typical chromatograrn of marker porphyrins is shown in Figure 1 . All of the porphyrins are resolved, including the compound with two COOH groups, mesoporphyrin. As expected, the more-polarcompoundselute first, the least-polar compoundslast. Figure 2 exemplifies the pattern for urine from an apparently healthy subject.This proffleis typical in that coproporphyrin predominates, and some uroporphyrin is present.
Several very small peaks that do not correspond to porphyrin markers may also be detectable. The mean excretion rate for healthy adults is 12 pg/24 h for uroporphyrin and 62 pg124 h for coproporphyrin (Table 1) (Table 1) .
This proffle, especially the very high heptacarboxyl peak, is virtually diagnostic of porphyria cutanea tarda.
The importance of sample preparation to accurate analyses must not be overlooked. In analytical-recovery studies for uroporphyrin and coproporphyrin, the pure compounds were added to normal urine. Virtually all of the coproporphyrin is recovered by this technique, whereas the lower recovery of uroporphyrmn-75 to 80%-is common to many porphyrin assays. Precision studies were carried out with a normal urine specimen containing an average of 7 ng of coproporphyrin and 0.8 ng of uroporphyrin per 100-pL injection. For routine urine analyses, the precision is quite acceptable, the coefficient of variation being 9.3% within-day and 11.8% between-day for coproporphyrin and 20% within-day and 38% between-day for uroporphyrin. Although the latter CVs may seem unacceptably high, they pose no clinical problem because the The linearity of HPLC response to porphyrins injected was verified by injecting inceasing amounts of uroporphyrin and measuring the peak heights. This relationship is linear to at least 25 ng of uroporphyrin. Because full-scale deflection corresponds to 30 ng of porphyrin, amounts of 1 ng or less are easily detected and measured.
Discussion
In this new method for quantifying urinary porphyria, unlike conventional methods, the use of HPLC separates the porphyrins according to the number of carboxyl groups, not simply into uro-and coproporphyrin fractions. Many techniques now in common use measure more than one compound as #{176}uroporphyrin" or "coproporphyrin," owing to cross contamination as well as measurement of minor porphyrin components; therefore, the HPLC method gives a more nearly accurate account for each porphyrin present. Moreover, the straightforward technique for urine preparation eliminates multiple solvent extractions, which are timeconsuming and often less than quantitative. The ease with which specimens are measured and calculated is another attractive feature.
The use of a step gradient represents a compromise between a continuous gradient and two separate injections into different solvent systems. Because urinary porphyrins differ by a charge of four from leastto most polar, it is not possible to well resolve both uro-and coproporphyrin with a single solvent. To perform two separate injections, each with a different solvent, would be tedious and introduce additional potential for error. A continuous gradient system offers a reasonable solution, but this requires the availability of two pumps and a gradient programmer. By carefully selecting solvents that will each elute two or three porphyruns, one can obtain a complete chromatogram with a single-step gradient system. In this way, only one injection is required, and the expense of a gradient system is spared.
Analysis for porphyrins invites the use of a fluorescence detector, since fluorescence is both more sensitive and more specific than absorbance. Our experience with a visible spectrophotometric detector, set to monitor absorbance at 405 nm, was disappointing.
Although its sensitivity was adequate to detect the porphyrins, numerous interfering substances in urine made interpretation of complete chromatograms difficult. Further, the change of solvents in the middle of the run produced a large peak (the result of refractive index change) that obliterated the hexa-and pentacarboxyl peaks. Neither problem was encountered with the fluorometer. Monitoring absorbance is quite suitable for determinations of uro-and coproporphyrin only, but not for a complete profile.
As mentioned above, specimen preparation is an important first step to remove interfering substances from the urine to be analyzed. Urinary porphyrins are tightly bound by DEAE-cellulose, which allows their separation from most other urinary components. A dramatic demonstration of this is the fact that whole urine fluoresces a yellow-green color, while the 0.1 molIL HC1 eluate from DEAE-cellulose fluoresces orange-red, typical of porphyria. The use of a SEP-PAK column, which contains a C18 resin similar to that of the analytical column, allows both buffer exchange and specimen concentration. Porphyria absorb to SEP-PAK in acidic solution and are eluted by a methanol/water mixture at neutral pH. The buffer exchange is important for two reasons: (a) the reversed-phase columns do not tolerate a pH <2.0 well, and (b) this step allows the acid eluate to be concentrated to a predetermined volume. An initial 10 mL of urine is thus reduced to 5 mL of an injectable methanol! water solution, providing a twofold increase in concentration from untreated urine. As many as 10 specimens can be prepared in about an hour. Analysis for urinary porphyria by this technique is rapid and requires little technologist time once specimens are prepared. All porphyria are eluted within 20 mm of injection, after which the initial solvent is run for 10 mm to reequilibrate the system for the next specimen. Technologist responsibilities during each 30-mm cycle are (a) specimen injection, (b) switching solvents at 7 miii, and (c) switching back to the initial solvent at 20 miii. Calculations involve measuring peak heights and use of a simple formula. Peak area measurement with an integrator is ideal, but peak heights can be used instead if the peaks are uniform in shape. Changing the switching time by 1 or 2 mm during elution will change retention times of the hexa-and pentacarboxyl porphyrins and coproporphyrin (four carboxyls) but will not affect peak heights or relative positions.
With increasing clinical experience, it should be possible to assign reference intervals for excretion to all urinary porphyria, not just uro-and coproporphyrin. This should be of value in the diagnosis of hereditary porphyrinopathies, in all but one of which there is increased excretion of porphyria in the urine. Results so far indicate that certain porphyrin proffles in urine are pathognomonic for specific porphyrias. Another important application of these determinations is in the field of occupational health. Several toxic substances (heavy metals, organic compounds) to which workers are commonly exposed affect the excretion of perphyruns in urine. By screening the porphyrin proffle in urine specimens, it may be possible to detect toxicity at an earlier stage.
